血管质量倡议注册研究中经股动脉颈动脉支架置入术的学习曲线
基于血管质量倡议(VQI)2005至2023年数据,分析2476名医师完成的43147例经股动脉颈动脉支架置入术(tfCAS)。随医师经验增加,症状性和无症状患者的院内卒中/死亡等结局均下降,但症状患者院内卒中/死亡率在达到235例前仍高于4%,无症状患者在达到13例前仍高于2%。
要点
- 症状患者tfCAS院内卒中/死亡率在医师完成235例前仍高于4%。
- 无症状患者tfCAS院内卒中/死亡率在医师完成13例前仍高于2%。
- 医师最初25例手术的院内卒中/死亡率明显较高。
核心结论
- tfCAS术后院内卒中/死亡和30天死亡率随医师经验增加而下降,学习曲线较长,与既往报告一致。
- 由于医师早期病例可能未纳入VQI,学习曲线可能被低估。
- 医师最初25例手术的院内卒中/死亡率仍相当高。
- 随着近期美国医疗保险和医疗补助服务中心(CMS)扩大tfCAS覆盖,大量医师将进入学习曲线早期阶段,可能增加术后并发症。
研究设计与样本
- 回顾性分析VQI注册研究中2005至2023年接受tfCAS的患者。
- 共分析2476名医师完成的43147例手术。
- 每名医师的手术按时间顺序分为12个类别,从第1-25例至351例以上。
- 主要结局为院内卒中/死亡率;次要结局包括院内卒中/死亡/心肌梗死(MI)、30天死亡率、院内卒中/短暂性脑缺血发作(TIA)及穿刺点并发症。
- 采用Cochran-Armitage检验和限制性立方样条广义线性模型分析结局与手术例数的关系,并用广义估计方程模型验证以考虑医师间变异。
主要发现
- 症状患者中,随医师经验增加(手术例数1-25至351+),院内卒中/死亡率从5.2%降至1.7%,院内卒中/死亡/MI从5.8%降至1.7%,30天死亡率从4.6%降至2.8%,院内卒中/TIA从5.0%降至1.1%,穿刺点并发症从4.1%降至1.1%(所有P值<.05)。
- 症状患者院内卒中/死亡率在医师完成235例前仍高于4%。
- 无症状患者中,随医师经验增加,院内卒中/死亡率从2.1%降至1.6%,院内卒中/死亡/MI从2.6%降至1.6%,30天死亡率从1.7%降至0.4%,院内卒中/TIA从2.8%降至1.6%(所有P值<.05)。
- 无症状患者院内卒中/死亡率在医师完成13例前仍高于2%。
关键数值与推荐
- 症状患者院内卒中/死亡率阈值建议为<4%,无症状患者为<2%,因约30%的CAS围手术期卒中/死亡发生在出院后。
临床怎么用
- 原文未据此给出推荐。
局限性
- 由于医师早期病例可能未纳入VQI,学习曲线可能被低估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: With the recent expansion of the Centers for Medicare and Medicaid Services coverage, transfemoral carotid artery stenting (tfCAS) is expected to play a larger role in the management of carotid disease. Existing research on the tfCAS learning curve, primarily conducted over a decade ago, may not adequately describe the current effect of physician experience on outcomes. Because approximately 30% of perioperative strokes/deaths post-CAS occur after discharge, appropriate thresholds for in-hospital event rates have been suggested to be <4% for symptomatic and <2% for asymptomatic patients. This study evaluates the tfCAS learning curve using Vascular Quality Initiative (VQI) data. METHODS: We identified VQI patients who underwent tfCAS between 2005 and 2023. Each physician's procedures were chronologically grouped into 12 categories, from procedure counts 1-25 to 351+. The primary outcome was in-hospital stroke/death rate; secondary outcomes were in-hospital stroke/death/myocardial infarction (MI), 30-day mortality, in-hospital stroke/transient ischemic attack (stroke/TIA), and access site complications. The relationship between outcomes and procedure counts was analyzed using the Cochran-Armitage test and a generalized linear model with restricted cubic splines. Our results were then validated using a generalized estimating equations model to account for the variability between physicians. RESULTS: We analyzed 43,147 procedures by 2476 physicians. In symptomatic patients, there was a decrease in rates of in-hospital stroke/death (procedure counts 1-25 to 351+: 5.2%-1.7%), in-hospital stroke/death/MI (5.8%-1.7%), 30-day mortality (4.6%-2.8%), in-hospital stroke/TIA (5.0%-1.1%), and access site complications (4.1%-1.1%) as physician experience increased (all P values < .05). The in-hospital stroke/death rate remained above 4% until 235 procedures. Similarly, in asymptomatic patients, there was a decrease in rates of in-hospital stroke/death (2.1%-1.6%), in-hospital stroke/death/MI (2.6%-1.6%), 30-day mortality (1.7%-0.4%), and in-hospital stroke/TIA (2.8%-1.6%) with increasing physician experience (all P values <.05). The in-hospital stroke/death rate remained above 2% until 13 procedures. CONCLUSIONS: In-hospital stroke/death and 30-day mortality rates after tfCAS decreased with increasing physician experience, showing a lengthy learning curve consistent with previous reports. Given that physicians' early cases may not be included in the VQI, the learning curve was likely underestimated. Nevertheless, a substantially high rate of in-hospital stroke/death was found in physicians' first 25 procedures. With the recent Centers for Medicare and Medicaid Services coverage expansion for tfCAS, a significant number of physicians would enter the early stage of the learning curve, potentially leading to increased postoperative complications.
引用
- Jabbour G, Yadavalli SD, Straus S, et al. Learning curve of transfemoral carotid artery stenting in the Vascular Quality Initiative registry. J Vasc Surg. 2024. PMID: 38428653. doi:10.1016/j.jvs.2024.02.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。